- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
CStone Pharmaceuticals (2616)
CStone Pharmaceuticals stock price live, this page displays HK 2616 stock exchange data. View the 2616 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the CStone Pharmaceuticals real time stock price chart below.
What Is the CStone Pharmaceuticals Stock Price Today?
The CStone Pharmaceuticals stock price today is 6.91.
What Is the Stock Symbol for CStone Pharmaceuticals?
The stock symbol for CStone Pharmaceuticals is ""2616.""
What Stock Exchange Does CStone Pharmaceuticals Trade On?
CStone Pharmaceuticals is listed and trades on the Hong Kong stock exchange.
Is CStone Pharmaceuticals a Good Stock to Buy?
Determining whether CStone Pharmaceuticals—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2616 quote. (ISIN: KYG2588M1006)
What Is the CStone Pharmaceuticals Stock Price Today?
The CStone Pharmaceuticals stock price today is 6.91.
What Is the Stock Symbol for CStone Pharmaceuticals?
The stock symbol for CStone Pharmaceuticals is ""2616.""
What Stock Exchange Does CStone Pharmaceuticals Trade On?
CStone Pharmaceuticals is listed and trades on the Hong Kong stock exchange.
Is CStone Pharmaceuticals a Good Stock to Buy?
Determining whether CStone Pharmaceuticals—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2616 quote. (ISIN: KYG2588M1006)
Hong Kong
Currency in HKD
6.91
-0.02(-0.29%)
Closed·
Fair Value
An estimate of a CStone's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.81
7.10
52 wk Range
1.21
8.00
2616 Scorecard
Full Analysis
Stock has taken a big hit over the last week
2616 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a CStone's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.817.10
52 wk Range
1.218.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
2616 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a CStone's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
6.55
Downside
-5.21%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
CStone Pharmaceuticals Company Profile
CStone Pharmaceuticals, a biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally. The company offers CEJEMLY (sugemalimab), a monoclonal antibody against programmed death (PD) ligand 1 for the treatment of non-small cell lung cancer (NSCLC), gastric adenocarcinoma/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, and relapsed or refractory natural killer/T cell lymphoma; GAVRETO (pralsetinib), a RET inhibitor to treat patients with advanced or metastatic RET-mutant medullary and RET fusion-positive thyroid cancers, as well as NSCLC and multiple tumors; and AYVAKIT (avapritinib), a KIT/PDGFRA inhibitor for the treatment of adults with unresectable or metastatic gastrointestinal stromal tumors harboring a PDGFRA exon 18 mutation, and systematic mastocytosis. Its product pipeline includes Nofazinlimab (CS 1003), a PD-1 antibody to treat patients with hepatocellular carcinoma. The company’s products also comprise CS1002, CS2009, CS2011, CS5007, CS5005, CS5008, CS5005-R, CS5006, and CS5009 for the treatment of solid tumors; CS5001 to treat solid tumors and hematologic malignancies; and CS2013 and CS2015 for the treatment of autoimmune diseases. CStone Pharmaceuticals was incorporated in 2015 and is headquartered in Suzhou, China.
Compare 2616 to Peers and Sector
Metrics to compare | 2616 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2616PeersSector | |
|---|---|---|---|---|
P/E Ratio | −102.5x | −19.8x | −0.5x | |
PEG Ratio | −1.35 | 0.27 | 0.00 | |
Price/Book | 25.7x | 6.8x | 2.6x | |
Price / LTM Sales | 23.0x | 21.9x | 3.3x | |
Upside (Analyst Target) | −5.4% | 3.2% | 42.9% | |
Fair Value Upside | Unlock | −13.2% | 6.2% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 6.55
(-5.21% Downside)
Earnings
Latest Release
Apr 28, 2025
EPS / Forecast
-0.08 / --
Revenue / Forecast
153.04M / --
People Also Watch
FAQ
What Stock Exchange Does CStone Trade On?
CStone is listed and trades on the Hong Kong Stock Exchange stock exchange.
What Is the Stock Symbol for CStone?
The stock symbol for CStone is "2616."
What Is the CStone Market Cap?
As of today, CStone market cap is 10.15B.
What Is CStone's Earnings Per Share (TTM)?
The CStone EPS (TTM) is -0.07.
From a Technical Analysis Perspective, Is 2616 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has CStone Stock Split?
CStone has split 0 times.
How Many Employees Does CStone Have?
CStone has 135 employees.
What is the current trading status of CStone (2616)?
As of 12 Aug 2025, CStone (2616) is trading at a price of 6.91, with a previous close of 6.93. The stock has fluctuated within a day range of 6.81 to 7.10, while its 52-week range spans from 1.21 to 8.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.